Nicholas A. Crossland

Nicholas A. Crossland

National Emerging Infectious Diseases Laboratories (NEIDL), Boston University

Affiliated withBoston UniversityBoston University Chobanian and Avedisian School of Medicine

Research Area

Biography

Nicholas A. Crossland has not added Biography.
If you are Nicholas A. Crossland and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1
Year
Iterative Bleaching Extends Multiplicity with Use of Staining Automation for Core Facilities
Publication title
2025

Other Publications

Article
Year
Quantification of Viral and Host Biomarkers in the Liver of Rhesus Macaques: A Longitudinal Study of Zaire Ebolavirus Strain Kikwit (EBOV/Kik).

The American journal of pathology| PubMed ID: 32275904

2020
2020
2021
Lung-resident memory B cells protect against bacterial pneumonia.

The Journal of clinical investigation| PubMed ID: 34060477

2021
Association of vaping with decreased vascular endothelial growth factor expression and decreased microvessel density in cutaneous wound healing tissue in rats.

Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society| PubMed ID: 34129265

2021
2022
2022
2022
2022
2022
2022
FeMV is a cathepsin-dependent unique morbillivirus infecting the kidneys of domestic cats.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 36251995

2022
2023
2023
2023
2023
2023
2023
2023
2023
Immune Signatures of SARS-CoV-2 Infection Resolution in Human Lung Tissues.

bioRxiv : the preprint server for biology| PubMed ID: 38496468

2024
2024
2024
2024
Inhibition of mRNA nuclear export promotes SARS-CoV-2 pathogenesis.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 38768348

2024
2024
2024
2024
Pre-existing H1N1 immunity reduces severe disease with bovine H5N1 influenza virus.

bioRxiv : the preprint server for biology| PubMed ID: 39484442

2024
2025
2025
2025
2025
2025
SARS-CoV-2 nsp15 enhances viral virulence by subverting host antiviral defenses.

Proceedings of the National Academy of Sciences of the United States of America| PubMed ID: 40504150

2025
2025
2025